EAHP 2012 Report – Compassionate use and off-label medicines
by Zara Qadir reporting on the presentation by Yechiel Hekster (pictured), Professor of Clinical Pharmacy, and a member of The Netherlands Medicines Evaluation Board.
by Zara Qadir reporting on the presentation by Yechiel Hekster (pictured), Professor of Clinical Pharmacy, and a member of The Netherlands Medicines Evaluation Board.
Zara Qadir interviews Dr Chantal Bélorgey (pictured), Head of Clinical Trial Development at the French national competent authority, Affsaps (Agence française de sécurité sanitaire des produits).
Emerging uses of EMA Approved Drugs – by Gary Finnegan – Several new medicines have been approved by the European Medicines Agency after recent meetings of its Committee… read more.
Emerging uses of EMA Approved Drugs – by Gary Finnegan – The European Medicines Agency is emerging from a turbulent spell which has seen the departure of one… read more.
World Health Matters (Sweden) – by Gary Finnegan – Scientists in Sweden believe that have identified a set of genetic variations which cause osteoporosis.
Tel Aviv University develops BL-7050 to ease the neuropathic pain of millions of sufferers.
Support is growing for increased collaboration between pharmaceutical companies and patients in research processes worldwide, according to a new report by healthcare intelligence company GBI Research.
Taken from the British Medical Journal (BMJ) – by Bruce Sylvester – A Study published on Dec. 20, 2011 in the British Medical Journal suggests that some children… read more.
EMA Highlights by Gary Finnegan – The EMA has launched a public consultation on its revised guidelines covering how potential cancer drugs are assessed. The document provides guidance… read more.
It is estimated that there are 2.9 million people in the UK diagnosed with diabetes1 and the incidence is increasing, as it is across the world, all the… read more.
Advertisment